Related Experiment Video
Updated: Jul 20, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Model-based design of growth-attenuated viruses
Kwang-Il Lim1, Tobias Lang, Vy Lam
1Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Developing computer models for live-virus vaccines, like vesicular stomatitis virus (VSV), helps link genetic changes to virus growth. This aids in engineering safer and more effective vaccines by controlling gene expression and viral replication.
Area of Science:
- Virology
- Vaccine Development
- Computational Biology
Background:
- Live-virus vaccines offer advantages in immunity but require attenuation for safety.
- Current attenuation methods lack clear understanding of underlying mechanisms.
- Rational genetic engineering offers potential for controlled vaccine attenuation.
Purpose of the Study:
- To develop a computational model for vesicular stomatitis virus (VSV) intracellular growth.
- To link specific genetic modifications to changes in VSV growth phenotype.
- To facilitate the rational engineering of live-virus vaccines.
Main Methods:
- Developed a computer model simulating VSV intracellular growth.
- Incorporated known VSV regulatory mechanisms and infection steps.
- Simulated genome rearrangements and gene position alterations.
Main Results:
- Model accurately predicted attenuation ranking for VSV strains with altered nucleocapsid gene positions.
- Simulations demonstrated that altering gene positions can attenuate VSV growth.
- Model showed potential for overexpressing immunogenic surface glycoprotein while attenuating growth.
Conclusions:
- Computational modeling provides a framework for understanding genotype-phenotype relationships in VSV.
- This approach can guide the rational design of attenuated live-virus vaccines.
- Linking genomic modifications to controlled gene expression and growth is key for vaccine engineering.
More Related Videos
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019